Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Jin Jang

Showing results (101-110 of 292) with videos related to

Pageof 30
Sort By:
Yonsei Medical Journal|June 13, 2015
Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia AShin Young Hyun, Seon Yang Park, Soon Yong Lee, et al.
Malaria Journal|December 22, 2009
Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjectsBeesan Tan, Himanshu Naik, In-Jin Jang, et al.
Clinical Therapeutics|November 20, 2009
Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteersKyu-pyo Kim, Bo-Hyung Kim, Kyoung Soo Lim, et al.
Basic & Clinical Pharmacology & Toxicology|December 21, 2011
Assessment of the analgesic effect of remifentanil using three pain models in healthy Korean volunteers: a randomized, controlled studyTae-Eun Kim, Kyu-Pyo Kim, Donghoon Shin, et al.
Pharmacology|March 23, 2012
Pharmacokinetics of lacosamide in healthy korean male volunteersSung Eun Kim, Namyi Gu, Bo-Hyung Kim, et al.
Drug Design, Development and Therapy|March 24, 2017
Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjectsDongseong Shin, SeungHwan Lee, Sojeong Yi, et al.
Clinical and Translational Science|March 4, 2024
Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjectsHeejae Won, Deok Yong Yoon, Sangmi Lee, et al.
Scientific Reports|December 21, 2019
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjectsYun Kim, Seonghae Yoon, Yewon Choi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 24, 2018
The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteersViktoria Moschetti, Maria Kim, Michael Sand, et al.
British Journal of Clinical Pharmacology|December 22, 2016
Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjectsSeokuee Kim, Hyewon Chung, SeungHwan Lee, et al.
Pageof 30

Showing results (101-110 of 292) with videos related to

Sort By:
Pageof 30
Yonsei Medical Journal|June 13, 2015
Efficacy, Safety, and Pharmacokinetics of Beroctocog Alfa in Patients Previously Treated for Hemophilia AShin Young Hyun, Seon Yang Park, Soon Yong Lee, et al.
Malaria Journal|December 22, 2009
Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjectsBeesan Tan, Himanshu Naik, In-Jin Jang, et al.
Clinical Therapeutics|November 20, 2009
Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteersKyu-pyo Kim, Bo-Hyung Kim, Kyoung Soo Lim, et al.
Basic & Clinical Pharmacology & Toxicology|December 21, 2011
Assessment of the analgesic effect of remifentanil using three pain models in healthy Korean volunteers: a randomized, controlled studyTae-Eun Kim, Kyu-Pyo Kim, Donghoon Shin, et al.
Pharmacology|March 23, 2012
Pharmacokinetics of lacosamide in healthy korean male volunteersSung Eun Kim, Namyi Gu, Bo-Hyung Kim, et al.
Drug Design, Development and Therapy|March 24, 2017
Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjectsDongseong Shin, SeungHwan Lee, Sojeong Yi, et al.
Clinical and Translational Science|March 4, 2024
Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjectsHeejae Won, Deok Yong Yoon, Sangmi Lee, et al.
Scientific Reports|December 21, 2019
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjectsYun Kim, Seonghae Yoon, Yewon Choi, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 24, 2018
The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteersViktoria Moschetti, Maria Kim, Michael Sand, et al.
British Journal of Clinical Pharmacology|December 22, 2016
Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjectsSeokuee Kim, Hyewon Chung, SeungHwan Lee, et al.
Pageof 30